Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-33

First 33 Last

Share
Profile

Follow
asx11

4,004 Posts.

427

25/10/23

16:21

Post #: 70533856
Share

Originally posted by Zeeshan: ↑

Not sure why you feel the need to respond to people in such a condescending way, but anyway you do you.All I have to say is that you get what you give.

The "people" or the pumpers shouldn't have picked the fight with me when i was merely commenting on the charts when it went bearish . The same "people" weren't bothered when i was commenting on the bullish chart. So yea , you get what you give or what goes around comes around.

On the questions / comments

Why do you instead think we'll keep going backwards until the next FDA decision?

Why the comparison with LDX?

This is no LDX etc etc

I have heard this excuse from emotional bulls about different stocks in different stock forum on HC.

they all behave more or less the same after a bad news (even if it is 99.9% approved, but still a rejection). Just like what happened with LDX , BOT has been punished after the FDA rejection. It was starting to get punished 3 days before the decision (remember I called the chart UGLY before the ann and I got abused by the BOT pumpers?) and that is what makes me think that BOT has been a leaky ship here as it was in the past, but that is just my opinion adding 2+2

6-9 months is a long time and FDA decision was the biggest announcement in the history of BOT to date.

no other announcement in the 6-9 months is going to be as big as the FDA decision so I dont expect price to go back up before the end of the year.

Also the Macro environment is going to be another killer for a spec stock like BOT

AIMHO

DYOR

Expand

It will be longer than 6 months. Approval will be in FY25 according to the company. +9 months def not 6-9.

Last edited by asx11: 25/10/23

BOT Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

PNN

Power gets set for 1000-metre maiden drilling program in Brazil

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

First 33 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 31.5¢		Change -0.005(1.56%)		Mkt cap ! $572.5M

Open	High	Low	Value	Volume
32.0¢	32.0¢	31.0¢	$1.366M	4.341M

Buyers (Bids)

No.	Vol.	Price($)
18	342765	31.0¢

Sellers (Offers)

Price($)	Vol.	No.
32.0¢	723414	18

View Market Depth

No.	Vol.	Price($)
16	336540	0.310
11	232799	0.305
36	572352	0.300
6	120637	0.295
7	148067	0.290

Price($)	Vol.	No.
0.320	623414	17
0.325	258370	4
0.330	119269	6
0.335	330000	3
0.340	409590	4

Last trade - 16.10pm 18/11/2024 (20 minute delay)

BOT (ASX) Chart

Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-33

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Power gets set for 1000-metre maiden drilling program in Brazil

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-33

Top Stories

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Power gets set for 1000-metre maiden drilling program in Brazil

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News